[HTML][HTML] Impairment of the autophagy–lysosomal pathway in Alzheimer's diseases: pathogenic mechanisms and therapeutic potential

W Zhang, C Xu, J Sun, HM Shen, J Wang… - … Pharmaceutica Sinica B, 2022 - Elsevier
Abstract Alzheimer's disease (AD), the most common neurodegenerative disorder, is
characterized by memory loss and cognitive dysfunction. The accumulation of misfolded …

Disorders of lysosomal acidification—The emerging role of v-ATPase in aging and neurodegenerative disease

DJ Colacurcio, RA Nixon - Ageing research reviews, 2016 - Elsevier
Autophagy and endocytosis deliver unneeded cellular materials to lysosomes for
degradation. Beyond processing cellular waste, lysosomes release metabolites and ions …

[HTML][HTML] Enhancing autophagy in Alzheimer's disease through drug repositioning

M Eshraghi, M Ahmadi, S Afshar, S Lorzadeh… - Pharmacology & …, 2022 - Elsevier
Alzheimer's disease (AD) is one of the biggest human health threats due to increases in
aging of the global population. Unfortunately, drugs for treating AD have been largely …

BACE1 inhibitor drugs in clinical trials for Alzheimer's disease

R Vassar - Alzheimer's research & therapy, 2014 - Springer
Abstract β-site amyloid precursor protein cleaving enzyme 1 (BACE1) is the β-secretase
enzyme required for the production of the neurotoxic β-amyloid (Aβ) peptide that is widely …

Presenilin 1 maintains lysosomal Ca2+ homeostasis via TRPML1 by regulating vATPase-mediated lysosome acidification

JH Lee, MK McBrayer, DM Wolfe, LJ Haslett, A Kumar… - Cell reports, 2015 - cell.com
Summary Presenilin 1 (PS1) deletion or Alzheimer's disease (AD)-linked mutations disrupt
lysosomal acidification and proteolysis, which inhibits autophagy. Here, we establish that …

[HTML][HTML] Microglia in Alzheimer's disease: activated, dysfunctional or degenerative

V Navarro, E Sanchez-Mejias, S Jimenez… - Frontiers in aging …, 2018 - frontiersin.org
Microglial activation has been considered a crucial player in the pathological process of
multiple human neurodegenerative diseases. In some of these pathologies, such as …

Transgenic mouse models of Alzheimer's disease: An integrative analysis

R Sanchez-Varo, M Mejias-Ortega… - International Journal of …, 2022 - mdpi.com
Alzheimer's disease (AD) constitutes the most prominent form of dementia among elderly
individuals worldwide. Disease modeling using murine transgenic mice was first initiated …

Autophagy failure in A lzheimer's disease and the role of defective lysosomal acidification

DM Wolfe, J Lee, A Kumar, S Lee… - European journal of …, 2013 - Wiley Online Library
Autophagy is a lysosomal degradative process which recycles cellular waste and eliminates
potentially toxic damaged organelles and protein aggregates. The important cytoprotective …

The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer's disease

T Kanekiyo, G Bu - Frontiers in aging neuroscience, 2014 - frontiersin.org
Accumulation and aggregation of amyloid-β (Aβ) peptides in the brain trigger the
development of progressive neurodegeneration and dementia associated with Alzheimer's …

Phagocytic clearance of presynaptic dystrophies by reactive astrocytes in Alzheimer's disease

A Gomez‐Arboledas, JC Davila, E Sanchez‐Mejias… - Glia, 2018 - Wiley Online Library
Reactive astrogliosis, a complex process characterized by cell hypertrophy and upregulation
of components of intermediate filaments, is a common feature in brains of Alzheimer's …